BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

WELLS FARGO & COMPANY/MN's Holding History (CIK: 0000072971)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 15,183,000 Value ($000) $17,097 Avg Close — Range —
Q3 2025
Shares 23,422,000 Value ($000) $23,146 Avg Close — Range —
Q2 2025
Shares 24,355,000 Value ($000) $22,777 Avg Close — Range —
Q1 2025
Shares 21,111,000 Value ($000) $19,021 Avg Close — Range —
Q4 2024
Shares 15,111,000 Value ($000) $12,947 Avg Close — Range —
Q3 2024
Shares 10,697,000 Value ($000) $8,929 Avg Close — Range —
Q2 2024
Shares 10,660,000 Value ($000) $8,595 Avg Close — Range —
Q1 2024
Shares 12,372,000 Value ($000) $10,189 Avg Close — Range —
Q4 2023
Shares 16,617,000 Value ($000) $14,016 Avg Close — Range —
Q3 2023
Shares 16,561,000 Value ($000) $12,567 Avg Close — Range —
Q2 2023
Shares 8,827,000 Value ($000) $5,440 Avg Close — Range —
Q1 2023
Shares 8,527,000 Value ($000) $5,452 Avg Close — Range —
Q4 2022
Shares 10,527,000 Value ($000) $4,082 Avg Close — Range —
Q3 2022
Shares 10,527,000 Value ($000) $4,389 Avg Close — Range —
Q2 2022
Shares 10,527,000 Value ($000) $4,263 Avg Close — Range —
Q1 2022
Shares 9,527,000 Value ($000) $4,533 Avg Close — Range —